Melosky, Barbara L.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America

Ho, Cheryl, Murray, Nevin, Laskin, Janessa, Melosky, Barbara, Anderson, Helen, Bebb, Gwyn

Journal:

Year:

2005

Language:

english

File:

PDF, 164 KB

english, 2005

2

Don’t jump to rash conclusions

Bebb, Gwyn, Boland, William, Melosky, Barbara

Journal:

Cancer Biology & Therapy

Year:

2011

Language:

english

File:

PDF, 693 KB

english, 2011

3

Immune Checkpoint-Inhibitors and Chemoradiation in Stage III Unresectable Non-Small Cell Lung Cancer

Melosky, Barbara, Juergens, Rosalyn, McLeod, Deanna, Leighl, Natasha, Brade, Anthony, Card, Paul B., Chu, Quincy

Journal:

Year:

2019

Language:

english

File:

PDF, 719 KB

english, 2019

4

Epoetin Alfa in Cancer Patients: Evidence-Based Guidelines

Robert Turner, Peter Anglin, Ronald Burkes, Félix Couture, William Evans, Glenwood Goss, Robert Grimshaw, Barbara Melosky, Alexander Paterson, Ian Quirt

Journal:

Journal of Pain and Symptom Management

Year:

2001

Language:

english

File:

PDF, 106 KB

english, 2001

5

Correlations ofEGFRmutations and increases inEGFRandHER2copy number to gefitinib response in a retrospective analysis of lung cancer patients

Trevor J Pugh, Gwyn Bebb, Lorena Barclay, Margaret Sutcliffe, John Fee, Chris Salski, Robert O'Connor, Cheryl Ho, Nevin Murray, Barbara Melosky, John English, Jeurgen Vielkind, Doug Horsman, Janessa J

Journal:

Year:

2007

Language:

english

File:

PDF, 691 KB

english, 2007

6

Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin

Sharlene Gill, Barbara Melosky, Lawrence Haley, Clifford ChanYan

Journal:

The American Journal of Medicine

Year:

2003

Language:

english

File:

PDF, 115 KB

english, 2003

7

P-212 Split-dose cisplatin (CDDP) and vinorelbine (VNR) in advanced non-small cell lung cancer (NSCLC): treatment outcomes including health-related quality of life (HRQL)

Lee, Christopher W., Murray, Nevin, Murphy, Kevin, Williams, Chris, MacNeil, Mary V., Martins, Heidi, Taylor, Marianne, Jones, Amanda, Khoo, Kong, Melosky, Barbara

Journal:

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003

8

Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis

Cromwell, Ian, van der Hoek, Kimberly, Malfair Taylor, Suzanne C., Melosky, Barbara, Peacock, Stuart

Journal:

Year:

2012

Language:

english

File:

PDF, 396 KB

english, 2012

9

A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced disease

Mariano, Caroline, Bosdet, Ian, Karsan, Aly, Ionescu, Diana, Murray, Nevin, Laskin, Janessa J., Zhai, Yongliang, Melosky, Barbara, Sun, Sophie, Ho, Cheryl

Journal:

Year:

2014

Language:

english

File:

PDF, 609 KB

english, 2014

10

Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer

Peixoto, Renata D'Alpino, Kumar, Aalok, Speers, Caroline, Renouf, Daniel, Kennecke, Hagen F., Lim, Howard J., Cheung, Winson Y., Melosky, Barbara, Gill, Sharlene

Journal:

Clinical Colorectal Cancer

Year:

2015

Language:

english

File:

PDF, 824 KB

english, 2015

11

Referral patterns in advanced non-small cell lung cancer: Impact on delivery of treatment and survival in a contemporary population based cohort

Noonan, Krista, Tong, King Mong, Laskin, Janessa, Melosky, Barbara, Sun, Sophie, Murray, Nevin, Ho, Cheryl

Journal:

Year:

2014

Language:

english

File:

PDF, 688 KB

english, 2014

12

Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Ho, Cheryl, Ramsden, Katherine, Zhai, Yongliang, Murray, Nevin, Sun, Sophie, Melosky, Barbara, Laskin, Janessa

Journal:

Journal of Thoracic Oncology

Year:

2014

Language:

english

File:

PDF, 273 KB

english, 2014

13

Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

Melosky, Barbara

Journal:

Frontiers in Oncology

Year:

2014

Language:

english

File:

PDF, 710 KB

english, 2014

14

Review of EGFRâ€‰TKIs in Metastatic NSCLC, Including Ongoing Trials

Melosky, Barbara

Journal:

Frontiers in Oncology

Year:

2014

Language:

english

File:

PDF, 404 KB

english, 2014

15

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFRâ€“TKIs

Melosky, Barbara, Hirsh, Vera

Journal:

Frontiers in Oncology

Year:

2014

Language:

english

File:

PDF, 944 KB

english, 2014

16

Treatment of AIDS-Related Cutaneous Kaposi's Sarcoma With Topical Alitretinoin (9-cis-Retinoic Acid) Gel

Walmsley, Sharon, Northfelt, Donald W., Melosky, Barbara, Conant, Marcus, Friedman-Kien, Alvin E., Wagner, Bridget

Journal:

JAIDS Journal of Acquired Immune Deficiency Syndromes

Year:

1999

File:

PDF, 7.93 MB

1999

17

Treatment of AIDS-Related Cutaneous Kaposi's Sarcoma With Topical Alitretinoin (9-cis-Retinoic Acid) Gel

Walmsley, Sharon, Northfelt, Donald W., Melosky, Barbara, Conant, Marcus, Friedman-Kien, Alvin E., Wagner, Bridget

Journal:

JAIDS Journal of Acquired Immune Deficiency Syndromes

Year:

1999

File:

PDF, 7.93 MB

1999

18

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis

Cromwell, Ian, van der Hoek, Kimberly, Melosky, Barbara, Peacock, Stuart

Journal:

Journal of Thoracic Oncology

Year:

2011

Language:

english

File:

PDF, 380 KB

english, 2011

19

ED11.01 Systemic Therapy for Advanced Oncogene-Driven NSCLC

Gandara, David R., Popat, Sanjay, Melosky, Barbara

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 333 KB

english, 2017

20

P1.02-011 Comparison of EGFR and KRAS Mutations in Archival Tissue and Circulating Tumor DNA: The Impact of Tumor Heterogeneity

Wang, Ying, Ho, Cheryl, Bushell, Kevin, Vandt, Solomon, Bosdet, Ian, Swanson, Lucas, Laskin, Janessa, Sun, Sophie, Melosky, Barbara, Murray, Nevin, Morin, Ryan, Karsan, Aly, Kennecke, Hagen

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 124 KB

english, 2017

21

An Evolving Algorithm to Select and Sequence Therapies in EGFR-mutation positive NSCLC: A Strategic Approach

Melosky, Barbara, Popat, Sanjay, Gandara, David R.

Journal:

Clinical Lung Cancer

Year:

2017

Language:

english

File:

PDF, 4.09 MB

english, 2017

22

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer

Marginean, Esmeralda Celia, Melosky, Barbara

Journal:

Archives of Pathology & Laboratory Medicine

Year:

2017

Language:

english

File:

PDF, 2.58 MB

english, 2017

23

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I, Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications

Marginean, Esmeralda Celia, Melosky, Barbara

Journal:

Archives of Pathology & Laboratory Medicine

Year:

2017

Language:

english

File:

PDF, 2.70 MB

english, 2017

24

B1-02: A Phase 1-2 study of the anti-sense oligonucleotide OGX-011 in combination with a platinum/gemcitabine regimen as first-line therapy for advanced non-small cell lung cancer

Laskin, Janessa, Hao, Desiree, Canil, Christina, Lee, Christopher, Melosky, B, Stephenson, Joe, Vincent, Mark, Gitlitz, Barbara, Cheng, Susanna, Murray, Nevin

Journal:

Journal of Thoracic Oncology

Year:

2007

Language:

english

File:

PDF, 174 KB

english, 2007

25

P3-108: Correlative genomics in a phase II clinical trial of first-line therapy of erlotinib for clinically selected patients with advanced non-small cell lung cancer

Laskin, Janessa J., Pugh, Trevor, Barclay, Lorena, Sutcliffe, Margaret, Ionescu, Diana, Lam, Stephen, Melosky, Barbara, Ho, Cheryl, Murray, Nevin, Lee, Christopher W., Marra, Marco

Journal:

Journal of Thoracic Oncology

Year:

2007

Language:

english

File:

PDF, 164 KB

english, 2007

26

Bevacizumab biosimilars: scientific justification for extrapolation of indications

Melosky, Barbara, Reardon, David A, Nixon, Andrew B, Subramanian, Janakiraman, Bair, Angel H, Jacobs, Ira

Journal:

Future Oncology

Year:

2018

Language:

english

File:

PDF, 1.42 MB

english, 2018

27

The role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic and Recurrent Non-Small Cell Lung Cancer: A Canadian National Consensus Statement

Ellis, Peter, Morzycki, Wojciech, Melosky, Barbara, Butts, Charles, Hirsh, Vera, Krasnoshtein, Flora, Murray, Nevin, Shepherd, Frances A, Soulieres, Denis, Tsao, Ming-Sound, Goss, Glenwood

Journal:

Current Oncology

Year:

2009

Language:

english

File:

PDF, 166 KB

english, 2009

28

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

Melosky, Barbara

Journal:

Frontiers in Oncology

Year:

2017

Language:

english

File:

PDF, 748 KB

english, 2017

29

Low Grade Neuroendocrine Tumors of the Lung

Melosky, Barbara

Journal:

Frontiers in Oncology

Year:

2017

Language:

english

File:

PDF, 1.44 MB

english, 2017

30

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

Melosky, Barbara

Journal:

Frontiers in Oncology

Year:

2017

Language:

english

File:

PDF, 90 KB

english, 2017

31

Impact of Afatinib Dose Modification on Safety and Effectiveness in Patients with EGFR Mutation-Positive Advanced NSCLC: Results from a Global Real-World Study (RealGiDo)

Halmos, Balazs, Tan, Eng-Huat, Soo, Ross A., Cadranel, Jacques, Lee, Min Ki, Foucher, Pascal, Hsia, Te-Chun, Hochmair, Maximilian, Griesinger, Frank, Hida, Toyoaki, Kim, Edward, Melosky, Barbara, Märt

Journal:

Year:

2018

Language:

english

File:

PDF, 501 KB

english, 2018

32

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

Melosky, Barbara L., Lim, Howard John, Davies, Janine Marie, Gill, Sharlene, Kollmannsberger, Christian K., Ho, Maria Yi, Vandt, Solomon A., Renouf, Daniel John

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2019

File:

PDF, 822 KB

2019

33

RETROSPECTIVE PRACTICE REVIEW OF METASTATIC NON-SMALL CELL LUNG CANCER TREATMENT WITH SECOND-LINE ERLOTINIB

Melosky, Barbara, Agulnik, Jason, Assi, Hazem

Journal:

Current Oncology

Year:

2008

Language:

english

File:

PDF, 104 KB

english, 2008

34

RETROSPECTIVE PRACTICE REVIEW OF METASTATIC NON-SMALL CELL LUNG CANCER TREATMENT WITH SECOND-LINE ERLOTINIB

Melosky, Barbara, Agulnik, Jason, Assi, Hazem

Journal:

Current Oncology

Year:

2008

File:

PDF, 104 KB

2008

35

Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219

Melosky, Barbara, Bradbury, Penelope, Tu, Dongsheng, Florescu, Marie, Reiman, Anthony, Nicholas, Garth, Basappa, Naveen, Rothenstein, Jeffrey, Goffin, John R., Laurie, Scott A., Wheatley-Price, Paul,

Journal:

Year:

2019

Language:

english

File:

PDF, 302 KB

english, 2019

36

Outcome differences between first and second-generation EGFR inhibitors in advanced EGFR mutated NSCLC in a large population-based cohort

Lau, Sally C., Chooback, Negar, Ho, Cheryl, Melosky, Barbara

Journal:

Clinical Lung Cancer

Year:

2019

Language:

english

File:

PDF, 979 KB

english, 2019

37

Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219

Melosky, Barbara, Bradbury, Penelope, Tu, Dongsheng, Florescu, Marie, Reiman, Anthony, Nicholas, Garth, Basappa, Naveen, Rothenstein, Jeffrey, Goffin, John R., Laurie, Scott A., Wheatley-Price, Paul,

Journal:

Year:

2019

File:

PDF, 302 KB

2019

38

Outcome differences between first and second-generation EGFR inhibitors in advanced EGFR mutated NSCLC in a large population-based cohort

Lau, Sally C., Chooback, Negar, Ho, Cheryl, Melosky, Barbara

Journal:

Clinical Lung Cancer

Year:

2019

File:

PDF, 979 KB

2019

39

PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer

Wang, Gang, Ionescu, Diana N., Lee, Cheng-Han, Hiruki, Tadaaki, Myers, Renelle, Shaipanich, Tawimas, Lam, Stephen, Melosky, Barbara, Zhou, Chen

Journal:

Year:

2019

Language:

english

File:

PDF, 773 KB

english, 2019

40

Development, Validation and Results from the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (iTEN) Model

Moldaver, Daniel, Hurry, Manjusha, Evans, William K., Cheema, Parneet K., Sangha, Randeep, Burkes, Ronald, Melosky, Barbara, Tran, Diana, Boehm, Darryl, Venkatesh, Jaya, Walisser, Susan, Orava, Erik,

Journal:

Year:

2019

Language:

english

File:

PDF, 2.73 MB

english, 2019

41

Lung cancer

Lam, Stephen, Ho, Cheryl, Melosky, Barbara

Journal:

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine

Year:

2020

File:

PDF, 729 KB

2020

42

Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer

Melosky, Barbara, Cheema, Parneet K., Brade, Anthony, McLeod, Deanna, Liu, Geoffrey, Wheatley Price, Paul, Jao, Kevin, Schellenberg, Devin D., Juergens, Rosalyn, Leighl, Natasha, Chu, Quincy

Journal:

Year:

2020

File:

PDF, 1.01 MB

2020